LN0504739
98% , 1675248-19-7
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB51997.60 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| color | Off-White to Pale Orange |
Description and Uses
Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
RELATED PRODUCTS
![N-Methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://img.chemicalbook.com/CAS/GIF/1260614-73-0.gif)
N-Methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
1260614-73-0
1260614-73-0
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
1354621-59-2
1354621-59-2
![N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://img.chemicalbook.com/CAS/20180629/GIF/1092578-45-4.gif)
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
1092578-45-4
1092578-45-4
1616761-00-2
Tofacitinib Impurity 19
2056104-91-5
2056104-91-5